Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Lung Cancer

Free Subscription 30.03.2026 2 Ann Surg Oncol 1 Cancer 1 Cancer Epidemiol Biomarkers Prev 1 Cancer Lett 1 Chest 1 Clin Lung Cancer 1 Eur J Cancer 2 Eur J Cardiothorac Surg 1 Int J Cancer 1 J Clin Oncol 2 JAMA Oncol 2 Lancet 4 Lung Cancer 1 Lung Cancer (Auckl) 3 N Engl J Med 2 Nat Med 2 PLoS One 1 Science 1 Thorax

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. YAN Y, Han Y, Niu Z, Zhang X, et al
   Conversion Surgery After Induction Therapy for Initially Unresectable Stage III Non-small Cell Lung Cancer: A Proof-of-Concept Trial.
   Ann Surg Oncol. 2026 Mar 25. doi: 10.1245/s10434-026-19461.
   PubMed         Abstract available
   
   
2. JIANG W, Chen S
   TRIM3 Suppresses Tumor Progression in Non-small-Cell Lung Cancer by Promoting PD-L1 Ubiquitination and Degradation.
   Ann Surg Oncol. 2026 Mar 23. doi: 10.1245/s10434-026-19339.
   PubMed         Abstract available
   
   

   
   Cancer

3. VAN TUIJL LA, Pan KY, Basten M, Vermeulen R, et al
   Psychosocial factors and the risk of cancer: An individual-participant data meta-analysis.
   Cancer. 2026;132:e70271.
   PubMed         Abstract available
   
   

   
   Cancer Epidemiol Biomarkers Prev

4. COOMBS LA, Zhou X, Reeder-Hayes KE, Diaz F, et al
   Exploring clinical pathways to a metastatic lung cancer diagnosis: A latent class analysis using North Carolina multi-payer claims data.
   Cancer Epidemiol Biomarkers Prev. 2026.
   PubMed         Abstract available
   
   

   
   Cancer Lett

5. EL-GAZZAR A, Aschenbrenner B, Forsthuber A, Kramer M, et al
   Targeting P2RY2 reprograms tumor immunity and inhibits tumor growth in non-small cell lung cancer.
   Cancer Lett. 2026 Mar 24:218448. doi: 10.1016/j.canlet.2026.218448.
   PubMed         Abstract available
   
   

   
   Chest

6. POTTER AL, Guo Q, Rettner B, Zhu A, et al
   The 2021 US Preventive Services Task Force Lung Cancer Screening Criteria Miss Many Patients Diagnosed with Early- and Late-Stage Lung Cancer: Analysis of Three Cohort Studies.
   Chest. 2026 Mar 24:S0012-3692(26)00380-6. doi: 10.1016/j.chest.2026.
   PubMed         Abstract available
   
   

   
   Clin Lung Cancer

7. CURT K, Datta R, Ramnath N, Green MD, et al
   Brief Report: Real-World Outcomes of Lurbinectedin in Veterans With Small Cell Lung Cancer.
   Clin Lung Cancer. 2026;27:17-21.
   PubMed        
   
   

   
   Eur J Cancer

8. BLOCKER S, Kim D, Cavalieri CC, Cannon S, et al
   Risk factors for CRS and ICANS with tarlatamab in small cell lung cancer and associated efficacy outcomes: Insights from clinical practice.
   Eur J Cancer. 2026;238:116686.
   PubMed         Abstract available
   
   

   
   Eur J Cardiothorac Surg

9. MESSINA G, Vicario G, Filippo VD, Pica DG, et al
   Intraoperative Contrast-Enhanced Ultrasound Versus Traditional Intraoperative Ultrasound for Detecting Lung Nodules During Robotic-assisted Thoracic Surgery.
   Eur J Cardiothorac Surg. 2026;68:ezaf434.
   PubMed         Abstract available
   
   
10. TSUBOI M, Wakelee H, Garassino MC, Gao S, et al
    A subgroup analysis of perioperative pembrolizumab in clinical stage II non-small-cell lung cancer from the randomized keynote-671 study.
    Eur J Cardiothorac Surg. 2026;68:ezag028.
    PubMed         Abstract available
    
    

    
    Int J Cancer

11. ACKER F, Wenger K, Reck M, Waller CF, et al
    Prediction of the individual risk for the development of brain metastases in patients with non-oncogene-addicted non-small cell lung cancer: Real-world data from the German prospective CRISP registry (AIO-TRK-0315).
    Int J Cancer. 2026 Mar 23. doi: 10.1002/ijc.70456.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

12. BESSE B, Subbiah V, Curigliano G, Bowles DW, et al
    Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion-Positive Non-Small Cell Lung Cancer.
    J Clin Oncol. 2026 Mar 26:JCO2501489. doi: 10.1200/JCO-25-01489.
    PubMed         Abstract available
    
    

    
    JAMA Oncol

13. SINGHI EK, Gandhi SJ, Antonoff MB
    Local Consolidative Therapy in Lung Cancer.
    JAMA Oncol. 2026 Mar 26. doi: 10.1001/jamaoncol.2026.0143.
    PubMed        
    
    
14. ZHOU H, Wang SC, Lee TTL, Ye ZH, et al
    Combination of Radiotherapy and Immunotherapy in Advanced Non-Small Cell Lung Cancer.
    JAMA Oncol. 2026 Mar 26. doi: 10.1001/jamaoncol.2026.0392.
    PubMed         Abstract available
    
    

    
    Lancet

15. HARRIS RA, Law JJ, Hao L, Situ D, et al
    Survival outcome of VATS compared with open lobectomy for lung cancer: an individual patient data meta-analysis of randomised trials.
    Lancet. 2026;407:1182-1190.
    PubMed         Abstract available
    
    
16. MERCIER O
    Surgical approach matters for long-term lung cancer outcomes.
    Lancet. 2026;407:1125-1126.
    PubMed        
    
    

    
    Lung Cancer

17. MARTIN LW, Wang X, Kozono D, Urbanic J, et al
    CHIO3: CHemotherapy combined with immune checkpoint inhibitor for operable stage IIIA/B (N2) Non-Small cell lung cancer (AFT-46).
    Lung Cancer. 2026;215:109374.
    PubMed         Abstract available
    
    
18. GOGA A, Soussi G, Mogenet A, Habert P, et al
    Single-center retrospective cohort study of lung cancer associated with interstitial lung disease: Prognostic factors and molecular profile.
    Lung Cancer. 2026;215:109379.
    PubMed         Abstract available
    
    
19. HUANG Y, Lin X, Li Z, Fang C, et al
    Colony-stimulating factors improve neoadjuvant immunochemotherapy efficacy in non-small-cell lung cancer without EGFR or ALK mutations: A double-center real-world retrospective study.
    Lung Cancer. 2026;215:109380.
    PubMed         Abstract available
    
    
20. LIN Z, Lyu Q, Li J, Fan L, et al
    Molecular subtyping of small-cell lung cancer in clinical practice: Primary tumor-lymph node concordance, intratumoral heterogeneity, and genomic context in a Chinese cohort.
    Lung Cancer. 2026;215:109377.
    PubMed         Abstract available
    
    

    
    Lung Cancer (Auckl)

21. LUMJIAKTASE P, Kemawichanurat N, Santiwiwas K, Kuttiyod T, et al
    Efficiency of Immunological Blood Biomarkers in Predicting Chemotherapy Response and Survival Outcome for Non-Targetable Advanced Non-Small Cell Lung Cancer Patients.
    Lung Cancer (Auckl). 2026;17:578622.
    PubMed         Abstract available
    
    

    
    N Engl J Med

22. PARK W, Kasi A, Spira AI, Paz-Ares Rodriguez L, et al
    Setidegrasib in Advanced Non-Small-Cell Lung Cancer and Pancreatic Cancer.
    N Engl J Med. 2026 Mar 25. doi: 10.1056/NEJMoa2600752.
    PubMed         Abstract available
    
    
23. WU L, Yu J, Liu W
    Sevabertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer.
    N Engl J Med. 2026;394:621-622.
    PubMed        
    
    
24. LE X, Brase JC, Bao W
    Sevabertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer. Reply.
    N Engl J Med. 2026;394:622.
    PubMed        
    
    

    
    Nat Med

25. WOZNITZA N, Smith L, Rawlinson J, Au-Yong I, et al
    AI-based chest X-ray prioritization in the lung cancer diagnostic pathway: the LungIMPACT randomized controlled trial.
    Nat Med. 2026 Mar 24. doi: 10.1038/s41591-026-04253.
    PubMed         Abstract available
    
    
26. LEE RW, Nair A, Balata H, Graham C, et al
    Implementation of the NHS England Lung Cancer Screening Programme over 5 years.
    Nat Med. 2026 Mar 23. doi: 10.1038/s41591-026-04292.
    PubMed         Abstract available
    
    

    
    PLoS One

27. MISAKI N, Sato K, Yamada K, Yokota N, et al
    Evaluation of the effects of indocyanine green administration dose and speed on blood concentration and fluorescence in thoracoscopic segmentectomy.
    PLoS One. 2026;21:e0345951.
    PubMed         Abstract available
    
    
28. BAPPI MI, Richter DJ, Kolekar SS, Kim K, et al
    HCLmNet: A unified hybrid continual learning strategy multimodal network for lung cancer survival prediction.
    PLoS One. 2026;21:e0316509.
    PubMed         Abstract available
    
    

    
    Science

29. CHAO YK, Wu M, Gong Q, Chen F, et al
    A genetically encoded device for transcriptome storage in mammalian cells.
    Science. 2026;391:eadz9353.
    PubMed         Abstract available
    
    

    
    Thorax

30. LE GAL A, Carli A, Salvator H, Sanchis-Borja M, et al
    Disseminated nocardiosis associated with anti-GM-CSF antibodies mimicking metastatic lung cancer.
    Thorax. 2026 Mar 23:thorax-2025-224527. doi: 10.1136/thorax-2025-224527.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum